NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q3 2023 Earnings

Nov 29Expected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.8
-1.2
-0.6
-0

Details

Expected EPS
-0.4864
Actual EPS
0
Surprise EPS
0.49
Surprise Percent
+100%

Description

⁨NewAmsterdam Pharma Company NV - Warrants (15/11/2027)⁩ (⁦NAMS+⁩) has reported earnings of ⁦0⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts